NASDAQ:MDB - MongoDB Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $349.50
  • Forecasted Upside: -5.28 %
  • Number of Analysts: 13
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 10 Buy Ratings
  • 0 Strong Buy Ratings
$368.98
▼ -15.14 (-3.94%)
1 month | 3 months | 12 months
Get New MongoDB Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MDB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MDB

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$349.50
▼ -5.28% Downside Potential
This price target is based on 13 analysts offering 12 month price targets for MongoDB in the last 3 months. The average price target is $349.50, with a high forecast of $465.00 and a low forecast of $150.00. The average price target represents a -5.28% upside from the last price of $368.98.
Buy
The current consensus among 13 contributing investment analysts is to buy stock in MongoDB. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 10 buy ratings
  • 4 hold ratings
  • 1 sell ratings
8/5/2019
  • 0 strong buy ratings
  • 10 buy ratings
  • 4 hold ratings
  • 1 sell ratings
11/3/2019
  • 0 strong buy ratings
  • 10 buy ratings
  • 5 hold ratings
  • 1 sell ratings
2/1/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 4 hold ratings
  • 1 sell ratings
5/1/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 5 hold ratings
  • 1 sell ratings
7/30/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 4 hold ratings
  • 1 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/27/2020
  • 0 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 0 sell ratings
1/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/19/2021Needham & Company LLCBoost Price TargetBuy$341.00 ➝ $394.00Low
i
1/13/2021Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target$354.00 ➝ $465.00Low
i
1/13/2021Smith Barney CitigroupBoost Price Target$354.00 ➝ $465.00Low
i
1/11/2021Piper SandlerBoost Price Target$328.00 ➝ $425.00Medium
i
1/11/2021BarclaysBoost Price TargetOverweight$331.00 ➝ $435.00Low
i
1/6/2021MacquarieInitiated CoverageOutperformN/A
i
1/5/2021OppenheimerBoost Price TargetOutperform$300.00 ➝ $400.00N/A
i
Rating by Ittai Kidron at Oppenheimer Holdings Inc.
12/17/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$295.00 ➝ $439.00High
i
12/9/2020DA DavidsonBoost Price TargetNeutral$250.00 ➝ $275.00High
i
12/9/2020Canaccord GenuityBoost Price TargetBuy$290.00 ➝ $315.00Low
i
12/9/2020Piper SandlerBoost Price TargetOverweight$310.00 ➝ $328.00High
i
12/9/2020Needham & Company LLCBoost Price TargetBuy$290.00 ➝ $341.00High
i
12/7/2020Morgan StanleyBoost Price TargetEqual Weight$270.00 ➝ $295.00Low
i
11/18/2020Needham & Company LLCReiterated RatingBuy$290.00Low
i
Rating by Jack Andrews at Needham & Company LLC
10/23/2020BarclaysBoost Price TargetOverweight$287.00 ➝ $331.00Low
i
9/24/2020FBN SecuritiesInitiated CoverageOutperform$260.00Low
i
9/3/2020DA DavidsonBoost Price TargetNeutral$215.00 ➝ $250.00High
i
9/3/2020Morgan StanleyBoost Price TargetEqual Weight$205.00 ➝ $270.00High
i
9/3/2020Canaccord GenuityBoost Price TargetBuy$245.00 ➝ $290.00High
i
9/3/2020Needham & Company LLCBoost Price TargetBuy$259.00 ➝ $290.00High
i
Rating by Jack Andrews at Needham & Company LLC
9/3/2020Stifel NicolausBoost Price TargetBuy$225.00 ➝ $320.00High
i
9/3/2020BarclaysBoost Price TargetOverweight$280.00 ➝ $287.00High
i
9/3/2020CitigroupBoost Price TargetBuy$275.00 ➝ $305.00High
i
9/3/2020The Goldman Sachs GroupBoost Price TargetNeutral$215.00 ➝ $245.00High
i
9/3/2020Piper SandlerBoost Price TargetOverweight$226.00 ➝ $310.00High
i
9/2/2020OppenheimerBoost Price TargetOutperform$240.00 ➝ $275.00High
i
Rating by Ittai Kidron at Oppenheimer Holdings Inc.
6/24/2020The Goldman Sachs GroupBoost Price TargetAverage ➝ Neutral$169.00 ➝ $215.00Low
i
6/11/2020Morgan StanleyBoost Price TargetEqual Weight$203.00 ➝ $205.00Low
i
6/5/2020DA DavidsonBoost Price TargetNeutral$105.00 ➝ $215.00Medium
i
6/5/2020Piper SandlerBoost Price TargetOverweight$138.00 ➝ $226.00High
i
6/5/2020Monness Crespi & HardtDowngradeBuy ➝ NeutralHigh
i
6/5/2020Canaccord GenuityBoost Price TargetBuy$130.00 ➝ $245.00High
i
6/5/2020OppenheimerReiterated RatingBuy$140.00 ➝ $240.00High
i
6/2/2020BarclaysBoost Price TargetOverweight$130.00 ➝ $275.00High
i
6/2/2020Needham & Company LLCBoost Price TargetBuy$170.00 ➝ $253.00High
i
Rating by Jack Andrews at Needham & Company LLC
6/1/2020Morgan StanleyBoost Price TargetEqual Weight$141.00 ➝ $203.00Low
i
5/28/2020CitigroupBoost Price TargetBuy$175.00 ➝ $275.00Medium
i
5/22/2020Stifel NicolausBoost Price TargetBuy$160.00 ➝ $225.00High
i
4/27/2020Needham & Company LLCLower Price TargetBuy$172.00 ➝ $170.00Medium
i
Rating by Jack Andrews at Needham & Company LLC
4/19/2020Stifel NicolausBoost Price TargetBuy$135.00 ➝ $160.00High
i
3/18/2020OppenheimerLower Price Target$155.00 ➝ $140.00High
i
Rating by Ittai Kidron at Oppenheimer Holdings Inc.
3/18/2020Piper SandlerLower Price TargetHigh
i
3/18/2020DA DavidsonLower Price TargetNeutral$143.00 ➝ $105.00High
i
3/18/2020Needham & Company LLCLower Price Target$189.00 ➝ $172.00High
i
Rating by Jack Andrews at Needham & Company LLC
3/18/2020Monness Crespi & HardtLower Price TargetBuy$190.00 ➝ $150.00High
i
3/18/2020CitigroupLower Price TargetBuy$200.00 ➝ $175.00High
i
3/18/2020Stifel NicolausLower Price TargetHold$185.00 ➝ $135.00High
i
3/16/2020Needham & Company LLCLower Price TargetPositive ➝ Buy$189.00 ➝ $172.00High
i
Rating by Jack Andrews at Needham & Company LLC
1/27/2020Needham & Company LLCReiterated RatingBuy$189.00Medium
i
Rating by Jack Andrews at Needham & Company LLC
1/13/2020Morgan StanleyBoost Price TargetEqual Weight$160.00 ➝ $171.00Medium
i
1/6/2020ArgusInitiated CoverageHoldHigh
i
12/10/2019Needham & Company LLCReiterated RatingBuy$189.00High
i
Rating by Jack Andrews at Needham & Company LLC
12/10/2019DA DavidsonReiterated RatingNeutral ➝ Positive$143.00High
i
12/10/2019Canaccord GenuityLower Price TargetBuy$185.00 ➝ $165.00High
i
12/10/2019Morgan StanleyBoost Price TargetEqual Weight$150.00 ➝ $160.00High
i
12/10/2019Nomura SecuritiesBoost Price TargetReduce$76.00 ➝ $78.00High
i
Rating by Christopher Eberle at Nomura Securities
10/28/2019Piper Jaffray CompaniesInitiated CoverageOverweight$158.00Low
i
10/16/2019Morgan StanleyLower Price TargetEqual ➝ Equal Weight$160.00 ➝ $150.00High
i
Rating by Sanjit Singh at Morgan Stanley
10/11/2019OppenheimerLower Price TargetOutperform$180.00 ➝ $155.00Low
i
9/6/2019BarclaysReiterated RatingBuyLow
i
9/5/2019Morgan StanleyBoost Price TargetEqual Weight$156.00 ➝ $160.00High
i
Rating by Sanjit Singh at Morgan Stanley
9/5/2019BarclaysBoost Price TargetOverweight$178.00 ➝ $179.00High
i
9/5/2019Stifel NicolausBoost Price TargetBuy$180.00 ➝ $185.00High
i
Rating by Brad Reback at Stifel Nicolaus
9/5/2019CitigroupBoost Price TargetBuy$184.00 ➝ $195.00High
i
Rating by Tyler Radke at Citigroup Inc.
9/5/2019Needham & Company LLCSet Price TargetBuy$184.00High
i
9/4/2019KeyCorpSet Price TargetBuy$188.00Low
i
Rating by Brent Bracelin at KeyCorp
8/30/2019Monness Crespi & HardtSet Price TargetBuy$185.00Low
i
Rating by Brian White at Monness Crespi & Hardt
8/30/2019Stifel NicolausSet Price TargetBuy$180.00Medium
i
Rating by Brad Reback at Stifel Nicolaus
8/28/2019Morgan StanleyBoost Price TargetEqual Weight$156.00Medium
i
Rating by Sanjit Singh at Morgan Stanley
8/27/2019CitigroupUpgradeNeutral ➝ Buy$162.00 ➝ $184.00Medium
i
Rating by Tyler Radke at Citigroup Inc.
8/13/2019Compass PointInitiated CoverageNeutral ➝ Neutral$155.00Medium
i
6/19/2019Nomura SecuritiesSet Price TargetSell$76.00High
i
Rating by Christopher Eberle at Nomura Securities
6/19/2019OppenheimerBoost Price TargetOutperform$160.00 ➝ $180.00Low
i
6/19/2019DA DavidsonBoost Price Target$165.00Medium
i
6/19/2019KeyCorpBoost Price TargetOverweight$165.00 ➝ $188.00High
i
6/19/2019Canaccord GenuityBoost Price TargetBuy ➝ Buy$160.00 ➝ $185.00Medium
i
6/19/2019William BlairReiterated RatingOutperformHigh
i
Rating by J. Ader at William Blair
6/19/2019Stifel NicolausBoost Price TargetBuy ➝ Positive$155.00 ➝ $180.00High
i
6/7/2019Morgan StanleySet Price TargetHold$156.00Medium
i
Rating by Sanjit Singh at Morgan Stanley
6/6/2019Nomura SecuritiesBoost Price TargetReduce$70.00 ➝ $76.00High
i
Rating by Christopher Eberle at Nomura Securities
6/6/2019DA DavidsonBoost Price TargetNeutral$140.00High
i
6/6/2019KeyCorpBoost Price TargetOverweight$150.00 ➝ $165.00High
i
6/6/2019Monness Crespi & HardtReiterated RatingBuy ➝ Buy$150.00 ➝ $185.00High
i
6/6/2019Canaccord GenuityReiterated RatingBuy$125.00 ➝ $160.00High
i
6/4/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$130.00 ➝ $159.00High
i
5/31/2019CitigroupSet Price TargetHold$155.00High
i
Rating by Tyler Radke at Citigroup Inc.
5/23/2019Morgan StanleyBoost Price TargetEqual Weight$124.00 ➝ $153.00Low
i
5/15/2019BarclaysBoost Price TargetOverweight ➝ Overweight$143.00 ➝ $178.00Medium
i
3/22/2019William BlairInitiated CoverageOutperform ➝ OutperformMedium
i
Rating by J. Ader at William Blair
3/14/2019CitigroupBoost Price TargetNeutral ➝ Neutral$94.00 ➝ $116.00High
i
3/14/2019Stifel NicolausBoost Price TargetBuy$95.00 ➝ $130.00High
i
3/14/2019Monness Crespi & HardtBoost Price TargetBuy$110.00 ➝ $150.00High
i
3/14/2019DA DavidsonReiterated RatingNeutralHigh
i
Rating by R. Jaluria at DA Davidson
3/14/2019Needham & Company LLCReiterated RatingBuy$108.00 ➝ $130.00High
i
3/14/2019Canaccord GenuityBoost Price TargetBuy ➝ Buy$95.00 ➝ $125.00High
i
3/14/2019KeyCorpBoost Price TargetOverweight ➝ Overweight$100.00 ➝ $150.00High
i
3/13/2019JMP SecuritiesReiterated RatingHoldHigh
i
2/28/2019Needham & Company LLCReiterated RatingBuy ➝ Buy$91.00 ➝ $108.00Low
i
2/26/2019Nomura SecuritiesSet Price TargetSell$63.00Medium
i
Rating by Christopher Eberle at Nomura Securities
12/14/2018Needham & Company LLCBoost Price TargetBuy$97.00Low
i
12/6/2018Needham & Company LLCBoost Price TargetBuy ➝ Buy$85.00 ➝ $91.00High
i
12/6/2018CitigroupBoost Price TargetNeutral ➝ Neutral$86.00 ➝ $94.00High
i
12/6/2018Canaccord GenuityReiterated RatingBuy ➝ Buy$78.00 ➝ $95.00High
i
12/6/2018Monness Crespi & HardtBoost Price TargetBuy ➝ Buy$90.00 ➝ $110.00High
i
10/17/2018CIBCInitiated CoverageOutperform ➝ Outperform$80.00Low
i
10/17/2018OppenheimerInitiated CoverageOutperform$80.00Low
i
10/2/2018DA DavidsonInitiated CoverageNeutral$80.00Low
i
Rating by R. Jaluria at DA Davidson
10/2/2018Nomura SecuritiesDowngradeNeutral ➝ Reduce$43.00 ➝ $63.00Low
i
9/17/2018BarclaysBoost Price TargetOverweight ➝ Overweight$79.00 ➝ $105.00Low
i
9/12/2018BTIG ResearchInitiated CoverageNeutralLow
i
9/11/2018CitigroupBoost Price TargetNeutral ➝ Neutral$56.00 ➝ $86.00Low
i
9/6/2018Nomura SecuritiesBoost Price TargetNeutral ➝ Neutral$40.00 ➝ $43.00High
i
9/6/2018BarclaysReiterated RatingOverweight ➝ Overweight$72.00 ➝ $79.00High
i
9/6/2018Monness Crespi & HardtBoost Price TargetBuy ➝ Buy$60.00 ➝ $90.00High
i
9/6/2018Canaccord GenuityBoost Price TargetBuy ➝ Buy$54.00 ➝ $78.00High
i
9/6/2018KeyCorpReiterated RatingOverweight ➝ Overweight$62.00 ➝ $88.00High
i
9/6/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$53.00 ➝ $80.00High
i
9/4/2018Needham & Company LLCBoost Price TargetBuy ➝ Buy$57.00 ➝ $85.00High
i
8/30/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$41.00 ➝ $66.00Medium
i
8/15/2018BarclaysBoost Price TargetOverweight ➝ Overweight$57.00 ➝ $72.00Low
i
7/9/2018Rosenblatt SecuritiesInitiated CoverageBuyLow
i
6/28/2018CitigroupInitiated CoverageNeutral$56.00Low
i
6/12/2018Needham & Company LLCBoost Price TargetBuy$52.00 ➝ $57.00High
i
6/7/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$47.00 ➝ $53.00Low
i
6/7/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$50.00 ➝ $62.00Low
i
6/7/2018Canaccord GenuityReiterated RatingBuy ➝ Buy$45.00 ➝ $54.00Low
i
6/7/2018Monness Crespi & HardtBoost Price TargetBuy$51.00 ➝ $60.00Low
i
6/7/2018BarclaysBoost Price TargetOverweight ➝ Overweight$47.00 ➝ $57.00High
i
6/5/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$35.00 ➝ $38.00Medium
i
6/5/2018Nomura SecuritiesBoost Price TargetNeutralMedium
i
6/4/2018Needham & Company LLCBoost Price TargetBuy$43.00 ➝ $52.00High
i
5/14/2018KeyCorpInitiated CoverageOverweight ➝ Overweight$50.00Medium
i
4/11/2018Monness Crespi & HardtInitiated CoverageBuy ➝ Buy$51.00Low
i
4/5/2018BarclaysBoost Price TargetOverweight ➝ Overweight$45.00 ➝ $47.00Low
i
3/14/2018Morgan StanleyReiterated RatingEqual Weight ➝ Equal Weight$32.00 ➝ $35.00High
i
3/14/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$34.00 ➝ $43.00High
i
3/14/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$34.00 ➝ $43.00High
i
3/14/2018Canaccord GenuityReiterated RatingBuy ➝ Buy$35.00 ➝ $45.00High
i
3/14/2018BarclaysBoost Price TargetOverweight ➝ Overweight$38.00 ➝ $45.00High
i
2/14/2018Needham & Company LLCUpgradeHold ➝ Buy$34.00High
i
1/30/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$33.00 ➝ $32.00High
i
1/23/2018Nomura SecuritiesInitiated CoverageNeutral ➝ Neutral$30.00High
i
12/13/2017Canaccord GenuityInitiated CoverageBuyMedium
i
11/15/2017Canaccord Genuity Group Inc. (CF.TO)Initiated CoverageBuy$35.00N/A
i
11/13/2017Morgan StanleyInitiated CoverageEqual ➝ Equal Weight$24.00 ➝ $31.00N/A
i
11/13/2017Stifel NicolausInitiated CoverageBuy ➝ Buy$34.00N/A
i
11/13/2017Canaccord GenuityInitiated CoverageBuy ➝ Buy$35.00N/A
i
11/13/2017JMP SecuritiesInitiated CoverageMkt Perform ➝ Market PerformN/A
i
11/13/2017The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$30.00N/A
i
11/13/2017BarclaysInitiated CoverageOverweight ➝ Overweight$38.00N/A
i
10/23/2017Needham & Company LLCInitiated CoverageHold ➝ HoldN/A
i
(Data available from 1/26/2016 forward)
MongoDB logo
MongoDB, Inc. operates as a general purpose database platform worldwide. The company offers MongoDB Enterprise Advanced, a subscription package for enterprise customers to run in the cloud, on-premise, or in a hybrid environment; MongoDB Atlas, a hosted multi-cloud database-as-a-service solution; and Community Server, a free-to-download version of its database, which includes the functionality that developers need to get started with MongoDB. It also provides professional services, such as consulting and training. The company was formerly known as 10gen, Inc. and changed its name to MongoDB, Inc. in August 2013. MongoDB, Inc. was founded in 2007 and is headquartered in New York, New York.
Read More

Today's Range

Now: $368.98
$355.35
$390.36

50 Day Range

MA: $358.32
$280.01
$396.00

52 Week Range

Now: $368.98
$93.81
$399.00

Volume

725,604 shs

Average Volume

747,177 shs

Market Capitalization

$22.24 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Frequently Asked Questions

What sell-side analysts currently cover shares of MongoDB?

The following Wall Street sell-side analysts have issued reports on MongoDB in the last twelve months: Barclays PLC, Canaccord Genuity, Citigroup Inc., Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell, DA Davidson, FBN Securities, Macquarie, Monness Crespi & Hardt, Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Piper Sandler, Smith Barney Citigroup, Stifel Nicolaus, The Goldman Sachs Group, Inc., and Zacks Investment Research.

What is the current price target for MongoDB?

14 Wall Street analysts have set twelve-month price targets for MongoDB in the last year. Their average twelve-month price target is $349.50, suggesting a possible downside of 5.3%. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell has the highest price target set, predicting MDB will reach $465.00 in the next twelve months. Monness Crespi & Hardt has the lowest price target set, forecasting a price of $150.00 for MongoDB in the next year.

What is the current consensus analyst rating for MongoDB?

MongoDB currently has 3 hold ratings and 10 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MDB will outperform the market and that investors should add to their positions of MongoDB.

What other companies compete with MongoDB?

How do I contact MongoDB's investor relations team?

MongoDB's physical mailing address is 1633 BROADWAY 38TH FLOOR, NEW YORK NY, 10019. The company's listed phone number is 646-727-4092 and its investor relations email address is [email protected] The official website for MongoDB is www.mongodb.com.